share_log

复锐医疗科技子公司Alma于日本建立直销渠道

Alma, a subsidiary of FuRi Medical Technology, establishes direct sales channels in Japan

PR Newswire ·  Nov 13, 2023 20:00

Continue to consolidate market leadership in the Asia-Pacific region

Hong Kong, November 14, 2023/PRNewswire/ -- Fului Medical Technology Co., Ltd. (EnglishSisram; Abbreviation“company”or“Rejuvenating Medical Technology”, stock code: 1696.HK, collectively referred to together with its subsidiaries“Group”), announced today that Alma Lasers (“Alma” for short), a subsidiary of the company, will establish a new direct sales channel in Japan. This is the sixth direct sales office that Alma has set up in the Asia-Pacific region so far. Alma is a global leader in the field of energy source medical aesthetic equipment and solutions. The establishment of a new direct sales office is a landmark for the company's development and will become another important growth engine for the company in the Asia-Pacific market. FuRui Medical Technology is a global beauty and health group. Its unique beauty and health ecosystem provides a diversified product portfolio to create a customer-centric brand. It has four major business segments: energy source medical equipment, injections and fillers, cosmetic and digital dentistry, and personal care.

Located in the heart of Tokyo, the new direct sales office will provide Japanese doctors with Alma's award-winning portfolio of energy source medical aesthetic equipment and leading medical aesthetic solutions.

As one of the three major medical and aesthetic markets in the Asia-Pacific region, Japan has maintained rapid and continuous growth in market size. Since entering the Japanese market in 2000, Alma has continued to be deeply involved in the market while actively developing business layout. Not only has it established sales channels in Japan, but it has also established stable cooperative relationships with clinics and well-known professionals all over Japan. The establishment of the Japan Direct Sales Office marks the company's commitment to a higher level of consumer in the Japanese market, providing better service to doctors in the Japanese market, better understanding patients' preferences and demands, and providing consumers with innovative solutions tailored to changing needs.

As an industry-leading energy source medical beauty equipment and solution provider that has been deeply involved in the Asia-Pacific market for more than 20 years, Alma adheres to the core consumer-centered guiding philosophy, continues to deepen the company's direct sales expansion and development strategy in key markets around the world, accurately positions and enhances the company's brand awareness in strategic markets around the world. Following the recent establishment of a direct sales channel in China, Japan became Alma's 11th direct sales market in the world.

Rejuvenating Medical Technology andAlmaCEOsLior Dayansir“The continued growth of Alma's business in the Asia Pacific market is a core element of our strengthened global leadership,” he said. We look forward to making concerted efforts with our Japanese partners to jointly provide patients with unique service values and experiences through Alma's effective solutions, thus opening a new era of aesthetic excellence.”

##

About FuRei Medical Technology

Fului Medical Technology Co., Ltd. (stock code: 1696.HK) is a global beauty and health group. Its unique beauty and health ecosystem provides a diversified product portfolio to create a customer-centered brand. Its business includes energy source medical equipment, injections and fillers, cosmetic and digital dentistry, personal care, etc. FuRui Medical Technology is a holding subsidiary of Fosun Pharmaceutical, a leading Chinese healthcare industry group. It was listed in Hong Kong, China in September 2017.

Foresui Medical Technology——Improving the quality of life

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment